Viatris, Inc. (VTRS)
13.44
-0.19
(-1.39%)
USD |
NASDAQ |
Apr 02, 16:00
13.44
0.00 (0.00%)
After-Hours: 20:00
Viatris Research and Development Expense (TTM) : 941.10M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Baxter International, Inc. | 503.00M |
| Pfizer Inc. | 10.25B |
| Edwards Lifesciences Corp. | 1.079B |
| Dentsply Sirona, Inc. | 150.00M |
| Theravance Biopharma, Inc. | 35.79M |